Details of the Drug
General Information of Drug (ID: DMFESG7)
Drug Name |
Aescin
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
escin Ib; UNII-QYK0D6H79O; 26339-90-2; QYK0D6H79O; CHEBI:2500; C55H86O24; escine Ib; escin-Ib; EscinI B; 6805-41-0; 11072-93-8; EINECS 247-619-4; Reparil (TN); Aescine (DCF); AESCIN IB(SH); AC1O52HI; CHEMBL505939; 8115AH; AKOS030530175; beta-D-Glucopyranosiduronic acid, (3beta,16alpha,21beta(Z),22alpha)-22-(acetyloxy)-16,24,28-trihydroxy-21-((2-methyl-1-oxo-2-butenyl)oxy)olean-12-en-3-yl O-beta-D-glucopyranosyl-(1.2)-O-(beta-D-glucopyranosyl-(1.4))-; N2164; D07912; C08921; 339E902; UNII-RUU8G67GQM component AXNVH
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||